Lessons From ASCO 2026 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Lessons From ASCO 2026

Precision oncology's next leap depends on biomarkers, data, and AI, with pathology at the center, say experts

  • By

  • Karan Arora

  • September 21, 2026

  • 10 min

Share

  • 1

    Precision oncology is shifting focus from targeted therapies to timely, actionable decisions for the right patients.

  • 2

    Pathology is becoming a central control point in precision oncology, integrating various data types to guide treatment decisions.

  • 3

    Clinicians face pressure to extract actionable insights from smaller tissue specimens due to advances in cancer detection.

  • 4

    AI and digital pathology are poised to enhance diagnostic efficiency and support informed clinical decisions in oncology.

  • 5

    Integrated workflows that connect various data types are essential for addressing the complexities of modern cancer care.

Original Source(s)

Lessons From ASCO 2026

  • by Karan Arora

  • September 21, 2026

Related Content

Measles Returns as Vaccination Rates Fall

As cases increase, laboratories and public health teams must be prepared to recognize and investigate suspected infections

Can Technology Make Pathology More Human? Part 3

Our panel discusses AI accountability, user trust, and desirable outcomes

The Third Reader

If the pathology report is our work, then making sure the patient can understand what we have said is part of our work as well